wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38128723-12DE0290-17A9-432B-8E5D-BDD5C019B7B2
Q38128723-12DE0290-17A9-432B-8E5D-BDD5C019B7B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38128723-12DE0290-17A9-432B-8E5D-BDD5C019B7B2
The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.
P2860
Q38128723-12DE0290-17A9-432B-8E5D-BDD5C019B7B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38128723-12DE0290-17A9-432B-8E5D-BDD5C019B7B2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
86b65f97443fbfea296ab708ad82ca6cb30eb428
P2860
Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.